XNXianjia Ning

Xianjia Ning

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xianjia Ning has a total of 213 co-authors. Here are the top co-authors by number of shared publications:

  • Jun Tu

    Department of Neurology, Tianjin Medical University General Hospital

    37 shared publications
  • Jinghua Wang

    Institute of Clinical Epidemiology & Evidence-Based Medicine, Tianjin Jizhou People’s Hospital, The Fifth Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

    34 shared publications
  • Jie Liu

    Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China

    21 shared publications
  • Jinghua Wang

    Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China

    19 shared publications
  • Hongfei Gu

    Department of Neurology, Tianjin Haibin People's Hospital. Tianjin, China

    12 shared publications
  • Qiuxing Lin

    Department of Neurology, Tianjin Medical University General Hospital

    10 shared publications

Latest Publications

  • Open Access

    Association between weight-adjusted waist index and carotid atherosclerosis in low-income population: a cross-sectional study

    by Huihui Xue, Haiying Wang, Juan Hao, Bingyi Li, Lifeng Wang, Chenxi Fan, Chunsheng Yang, Jinghua Wang, Xianjia Ning, Yan Li

  • Open Access

    Glucose tolerance phenotypes and risks of incident first-ever stroke and all-cause mortality in low-income rural Chinese adults: a population-based prospective cohort study

    by Lei Zhang, Xiao Li, Juan Hao, Chenxi Fan, Jun Tu, Jinghua Wang, Xianjia Ning, Yaogang Wang, Yan Li

    Background and objective: Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are common intermediate hyperglycaemic states, yet most cohorts have compared diabetes with non-diabetes, or have relied on fasting glucose alone, so the stroke risk gradient across the full glucose tolerance spectrum and the relative prognostic value of fasting versus postload glycaemia remain unresolved. Evidence is particularly scarce for low-income rural Chinese populations, in whom vascular risk factors cluster while chronic-disease management and screening resources are limited. This study aimed to investigate the associations of glucose tolerance status with incident first-ever post-baseline stroke and all-cause mortality among low-income rural adults in China. Methods: This population-based prospective cohort study included 2,087 adults from a low-income rural community in northern China who underwent a baseline examination including a 75-g oral glucose tolerance test (OGTT) in 2019. Among them, 2,057 participants with valid baseline examination dates were included in the time-to-event analyses, contributing 13,074.9 person-years for stroke and 13,477.4 person-years for mortality over a mean follow-up of 6.4 years. Baseline glucose tolerance status was classified as normal glucose tolerance (NGT), IFG, IGT, or diabetes according to the WHO/IDF criteria. Incident first-ever post-baseline stroke was defined as the first stroke event occurring after the 2019 baseline examination; participants with a stroke before baseline were excluded from this analysis, and all-cause mortality was recorded during follow-up. Incidence rates were calculated per 1,000 person-years and were additionally standardised for age and sex by the direct method. Cox proportional hazards regression models were used to estimate HRs and 95% CIs. The primary multivariable model (Model 2) was adjusted for sex, age group, smoking, drinking and eGFR; metabolic syndrome was added only in Model 3 and examined separately, because it shares glycaemic components with the exposure. In addition, fasting glucose and 2-h postload glucose were analysed as continuous variables in separate models, so that fasting and postload glycaemia could be compared without inducing collinearity. Proportional hazards were assessed using scaled Schoenfeld residuals, and multiple-imputation, Fine–Gray competing-risk and prespecified subgroup analyses were performed as sensitivity analyses. Results: During follow-up, 121 participants developed incident first-ever post-baseline stroke and 68 died from any cause, corresponding to overall incidence rates of 9.25 and 5.05 per 1,000 person-years, respectively. For incident stroke, the incidence rates were 7.55, 5.40, 12.74, and 14.06 per 1,000 person-years in the NGT (n = 1,324; 63.4%), IFG (n = 86; 4.1%), IGT (n = 449; 21.5%), and diabetes (n = 228; 10.9%) groups, respectively; for all-cause mortality the corresponding rates were 4.68, 1.77, 6.27 and 6.05 per 1,000 person-years. In crude analyses, both IGT (HR 1.69, 95% CI 1.11–2.55, *P* = 0.013) and diabetes (HR 1.85, 95% CI 1.12–3.06, *P* = 0.016) were associated with a higher risk of incident first-ever stroke compared with NGT. In the primary multivariable model (Model 2), both IGT (HR 1.58, 95% CI 1.03–2.41, *P* = 0.036) and diabetes (HR 1.69, 95% CI 1.02–2.81, *P* = 0.043) remained associated with incident stroke, whereas IFG did not (HR 0.78, 95% CI 0.25–2.51, *P* = 0.682). Adding metabolic syndrome (Model 3) attenuated both estimates and rendered diabetes non-significant (IGT: HR 1.55, 95% CI 1.01–2.39, *P* = 0.046; diabetes: HR 1.63, 95% CI 0.96–2.79, *P* = 0.071). No glucose tolerance subtype was significantly associated with all-cause mortality in any model. In continuous analyses modelled separately, both fasting glucose (HR 1.18 per 1 mmol/L, 95% CI 1.01–1.38, *P* = 0.035) and 2-h postload glucose (HR 1.07 per 1 mmol/L, 95% CI 1.02–1.13, *P* = 0.008) were associated with incident stroke; per standard deviation the postload association was the stronger of the two (HR 1.23, 95% CI 1.05–1.42 versus HR 1.17, 95% CI 1.01–1.35). Neither measure was associated with mortality. Conclusion: Three conclusions follow. First, in this specific setting — a low-income rural Chinese community with clustered vascular risk factors and limited screening capacity — both IGT and diabetes were associated with an increased risk of incident first-ever stroke, whereas isolated IFG was not. Second, postload glycaemia carried more prognostic information for stroke than fasting glycaemia: the postload association was the stronger of the two per standard deviation, and only the postload phenotype (IGT) showed an excess risk in the categorical analysis, while the continuous fasting association appeared to be driven largely by participants in the diabetes range rather than by isolated fasting hyperglycaemia. Third, for grassroots public-health practice these findings identify IGT as a candidate phenotype for earlier vascular risk assessment; whether adding postload measurement to existing screening improves outcomes remains to be tested directly.

  • Open Access

    Changing epidemiology of non-occupational acute carbon monoxide poisoning and the increasing share of older adults during the clean heating transition: a 10-year emergency department study in rural Tianjin, China

    by Wei Kang, Yanqiu Du, Miao Zhao, Jisheng Yang, Jian Liang, Xin Wang, Xianjia Ning, Guohua Zhao

    Background and Objective: Non-occupational Acute Carbon Monoxide Poisoning (ACOP) remains a preventable emergency condition in northern rural China, where winter heating and indoor combustion have historically been important exposure sources. In rural Tianjin, the clean heating transition period was accompanied by a substantial decline in the overall incidence of non-occupational ACOP, while the residual burden shifted toward older adults and lifestyle-related exposure sources. However, whether this transition has changed the epidemiological profile of non-occupational ACOP, particularly the residual risk among older adults, remains unclear. This study aimed to examine changes in the incidence, demographic profile, exposure sources, and severity of non-occupational ACOP during the clean heating transition in rural Tianjin, China, with special attention to older adults. Methods: This single-center retrospective observational study included patients with non-occupational ACOP who presented to the Emergency Department of Tianjin Jizhou District People’s Hospital between January 2016 and December 2025. The study period was divided into a policy construction and transition period (2016–2019) and a policy implementation and consolidation period (2020–2025). Annual emergency department-attended (ED- attended) incidence rates were calculated using resident population data. Demographic characteristics, exposure sources, seasonal distribution, clinical severity, and outcomes were compared between the two periods. Negative binomial regression was used to estimate incidence rate ratios because the annual case counts were substantially overdispersed, with quasi-Poisson, robust-variance Poisson and standard Poisson models fitted as concordant sensitivity analyses, and exploratory logistic regression was performed to assess factors associated with severe poisoning, including death. Results: A total of 3,923 patients were included, with 2,241 cases during 2016–2019 and 1,682 cases during 2020–2025. The ED- attended incidence, calculated using emergency department-treated ACOP cases and resident population denominators, decreased from 0.620 to 0.356 per 1,000 population, corresponding to a 42.7% reduction during 2020–2025 (negative binomial IRR = 0.573, 95% CI: 0.432–0.759, P < 0.001). The demographic profile shifted toward older adults, with the proportion of patients aged ≥ 65 years increasing from 27.4 to 37.1% ( P < 0.001). Coal stove heating remained the dominant exposure source but decreased from 94.1 to 89.8%, whereas charcoal hotpot-related poisoning increased from 4.2 to 9.1% (both P < 0.001). The overall severity profile showed a higher proportion of mild cases in the later period; however, severe poisoning among older adults increased from 0.8 to 2.4% ( P = 0.040). These patterns persisted in sensitivity and heating-season restricted analyses. Conclusion: During the clean heating transition in rural Tianjin, the ED-attended incidence of non-occupational acute carbon monoxide poisoning declined substantially in both age groups, but older adults came to account for an increasing share of the remaining cases, and charcoal hotpot use accounted for a growing proportion of residual exposures. These findings suggest that clean heating consolidation should be complemented by targeted geriatric risk management, winter safety education, carbon monoxide alarm promotion, safe charcoal use, and community-based prevention strategies for older adults living in rural and semi-rural settings.

  • Open Access

    Association of N-butylphthalide treatment with 1-year activities-of-daily-living recovery in convalescent ischemic stroke patients with chronic disease burden: a post-marketing real-world non-randomized controlled study

    by Xiaobing Tian, Xiyu Zhao, Lifeng Wang, Hongyan Lu, Juan Hao, Zhiquan Liu, Chenxi Fan, Xianjia Ning, Yan Li

    Background and objective: ADL recovery is essential for maintaining independence and reducing care burden after IS, particularly in patients with chronic vascular-metabolic disease burden. Although NBP has been studied for acute treatment, recurrence prevention, and cognitive protection, its association with ADL recovery in convalescent IS remains unclear. This study evaluated whether NBP treatment was associated with 1-year ADL recovery in a post-marketing real-world non-randomized controlled study. Methods: This was a post-marketing, real-world, prospective, non-randomized controlled study conducted in Jizhou District, Tianjin, China. Patients received either NBP plus basic treatment or basic treatment alone and were followed for 12 months. The primary outcome was change in BI score from baseline to 1 year. Secondary outcomes included change in mRS score, mRS >2, BI ≤ 60, and item-level BI changes. Chronic disease burden was defined as the cumulative number of hypertension, diabetes, hyperlipidemia, obesity, and coronary heart disease. Multivariable regression, subgroup analyses, IPTW analysis, and conservative death-imputation analysis were performed. This post-marketing, real-world, prospective, non-randomized controlled study was registered in the Chinese Clinical Trial Registry (ChiCTR2000039118). Results: Among 1,190 enrolled patients, 1,095 completed 1-year functional assessment, including 533 in the NBP group and 562 in the control group. Patients receiving NBP had slightly worse baseline mRS scores and a higher chronic disease burden than controls. At 1 year, the NBP group showed greater BI improvement than the control group (1.31 ± 13.99 vs. −1.11 ± 15.56; P = 0.0067), whereas change in mRS did not differ significantly (−0.18 ± 0.96 vs. −0.17 ± 1.05; P = 0.877). Item-level analyses showed greater improvements in grooming, toilet use, feeding, transfers, mobility on level surfaces, dressing, and stair climbing. In the fully adjusted model, NBP treatment remained associated with greater BI improvement (β = 2.40, 95% CI: 0.77–4.03; P = 0.0038), but not with mRS change. NBP was also associated with lower adjusted odds of ADL dependency at 1 year. The association with BI improvement remained significant in IPTW and conservative death-imputation analyses. Conclusion: In this post-marketing real-world non-randomized controlled study, NBP treatment was associated with better 1-year ADL recovery in convalescent IS patients with chronic disease burden, mainly reflected by BI improvement and self-care or mobility-related gains rather than global disability change. These findings support ADL-centered assessment in long-term post-stroke care and suggest that functional recovery should be considered alongside recurrent event prevention and cognitive protection in aging stroke populations. Clinical Trial Registration: [ChiCTR2000039118]; http://www.chictr.org.cn .

  • Open Access

    Influenza awareness, vaccination rates, and influencing factors among rural elderly population: a population-based cross-sectional study

    by Yunhan Fei, Jie Liu, Xiao Li, Juan Hao, Yuting Lu, Jun Tu, Jinghua Wang, Keliang Xie, Chunsheng Yang, Xianjia Ning

    Influenza-related respiratory diseases account for approximately 88,000 deaths annually in China. Vaccination against influenza is the most effective measu

  • Open Access

    Association between LDL-C/HDL-C ratio and long-term carotid plaque risk in middle-aged and elderly rural populations: a prospective population study

    by Yingzhe Shao, Juan Hao, Hailu Zhang, Yixin Chen, Jun Tu, Xianjia Ning, Yan Li

    Background: Atherosclerotic cardiovascular and cerebrovascular diseases are still the main cause of global incidence rate and mortality. The LDL-C/HDL-C ratio (LHR) has been identified as a potential biomarker for cardiovascular risk. However, the relationship between it and the long-term risk of carotid plaques is not yet clear, especially in low-income populations in China. Methods: This prospective cohort study included adults aged ≥45 years without carotid plaque at baseline from low-income rural areas of Tianjin, China. Baseline characteristics were collected in 2014, and follow-up data were obtained in 2019. The primary outcome was the development of new carotid plaques, assessed using carotid ultrasound. The relationship between the LDL-C/HDL-C ratio (LHR) and new carotid plaques was analyzed using multifactorial logistic regression, with the presence or absence of new-onset plaques as the dependent variable. Additionally, we utilized restricted cubic spline (RCS) regression to visually present the potential nonlinear relationship between LHR and the risk of carotid plaque. Results: Over the six-year follow-up period, 606 participants (38.3%) developed new carotid plaques. Higher LHR was significantly associated with an increased risk of new carotid plaques, with each unit increase in LHR corresponding to a 35.9% higher risk (OR = 1.359, 95% CI: 1.180–1.566, p < 0.001). The RCS curve indicated a non-linear positive association between LHR and the likelihood of carotid plaques ( p for non-linearity = 0.019), with an optimal cut-off at 1.257. Logistic regression analysis confirmed that LHR > 1.257 was linked to increased odds of carotid plaques in both unadjusted (OR: 1.80, p < 0.001) and adjusted models (OR: 1.835, p < 0.001), with LHR ≤ 1.257 serving as the reference. In subgroup analysis, all subgroups consistently demonstrated a significant association between increased LHR (all OR > 1). Conclusion: The research results indicate that there is a non-linear positive correlation between LHR and the long-term risk of carotid plaques in middle-aged and elderly populations, suggesting that LHR may be an effective indicator for screening carotid plaques in grassroots middle-aged and elderly populations.

  • Open Access

    TyG-ABSI as a novel metabolic obesity indicator for carotid plaque: an explainable machine learning study using SHAP in low-income population

    by Juan Hao, Ran Chen, Diliyaer Abudukeremu, Xiao Li, Yiwei Zhang, Lifeng Wang, Chenxi Fan, Chunsheng Yang, Xianjia Ning, Jinghua Wang, et al.

    This investigation aimed to evaluate the relationship between a combined triglyceride-glucose (TyG)–adiposity index and carotid plaque within a low-income rural cohort, and to apply machine-learning models alongside SHapley Additive exPlanations (SHAP) for detailed interpretation. We conducted a cross-sectional analysis of 1,960 adults enrolled from documented low-income rural areas. Sociodemographic variables, lifestyle habits, anthropometric indices, and biochemical markers were systematically recorded. A binary logistic model served to predict carotid plaque, while restricted cubic splines (RCS) examined possible non-linear associations between the TyG–ABSI composite (triglyceride-glucose index combined with a body-shape index) and plaque risk. Next, ten machine-learning classifiers—Logistic Regression, Support Vector Machine (SVM), Gradient Boosting Machine (GBM), Neural Network, Random Forest, XGBoost, K-Nearest Neighbors (KNN), AdaBoost, LightGBM, and CatBoost—were trained and internally validated. Hierarchical 5-fold cross-validation was implemented in the training set to fine-tune the hyperparameters. Model performance was evaluated on both the training and validation sets using accuracy, sensitivity, specificity, precision, F1 score, and the area under the ROC curve (AUC). SHAP values were computed to quantify and visualize feature contributions. Among 1,960 participants, the overall prevalence of carotid plaque was 48.3%, with 59.0% in men and 41.7% in women. In multivariable-adjusted logistic regression, sex, age, systolic blood pressure (SBP), and TyG-ABSI were independently associated with carotid plaque. Each one-unit increment in TyG-ABSI corresponded to a 20% higher odds of plaque presence (OR = 1.20; 95% CI 1.02–1.42; P = 0.025). RCS modelling revealed a non-linear relationship (P for non-linearity = 0.038), risk rose with TyG-ABSI up to = 7.75 and then declined, yielding an inverted-U trend around this inflection point. Among ML algorithms, logistic regression achieved the best generalization on the validation set (accuracy = 0.665, F1 = 0.58, AUC = 0.67). SHAP analysis confirmed the predictive importance of TyG-ABSI. In this cross-sectional study of a low-income rural population, the TyG-ABSI index demonstrated a significant nonlinear relationship with carotid plaque risk. Among the machine learning algorithms evaluated, logistic regression achieved the highest predictive accuracy. SHAP-based visualizations further revealed the key features driving this distinction. Future research is needed to validate causal associations through prospective studies. Not applicable.


  • Open Access

    Long-Term Benefits of N-Butylphthalide in Preventing Ischemic Stroke Recurrence: A 12-Month Prospective Study

    by Wei Liu, Yingzhe Shao, Jie Liu, Juan Hao, Yuting Lu, Li Yang, Jinghua Wang, Xianjia Ning

    Purpose: This study evaluated the effects of 12 months of NBP treatment on stroke recurrence and examined the influence of age and gender on its efficacy. Methods: A prospective cohort of 1109 patients with non-cardioembolic ischemic stroke (IS) within six months was divided into NBP (n = 538) and control (n = 571) groups. The NBP group received NBP plus standard treatment, while the control group received standard treatment alone. Primary outcomes were recurrent ischemic and hemorrhagic stroke over 12 months. Secondary outcomes included functional status (modified Rankin Scale, m-RS) and all-cause mortality. Results: NBP reduced recurrent IS by 39% compared to controls (RR:0.61,95% CI:0.40– 0.93, P=0.022) and total stroke events by 39.6% (RR:0.60,95% CI:0.40– 0.91,P=0.016). Protective effects were more significant in males (RR:0.52,95% CI:0.30– 0.91, P=0.021 vs RR:0.53,95% CI:0.40– 0.91,P=0.021) and in patients under 70 years (P< 0.05). Functional outcomes (modified Rankin Scale and Barthel index) and all-cause mortality did not differ significantly between groups (all P> 0.05). Conclusion: NBP significantly reduces stroke recurrence and overall vascular events, especially in males and younger patients. While it does not improve functional outcomes or mortality, NBP demonstrates substantial preventive value for recurrent strokes.


  • Open Access

    Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study

    by Qingqing Han, Xiyu Zhao, Yingzhe Shao, Fengtao Tan, Haotian Wen, Di Wang, Xiao Li, Yunfan Wang, Jun Tu, Lifeng Wang, et al.

    Background: Cognitive decline is a significant concern for stroke survivors, affecting their quality of life and increasing their burden on the healthcare system. DL-3-n-butylphthalide (butylphthalide) has shown efficacy in the short-term treatment of various cognitive impairments. This study evaluated the efficacy of butylphthalide in preventing cognitive decline over a 12-month period in patients with ischaemic stroke. Methods: This prospective following-up study involved patients newly diagnosed with ischaemic stroke between 1 month and 6 months after stroke onset and not in the acute phase. Patients were assigned to either the butylphthalide or control group. Cognitive function was assessed using the mini-mental state examination (MMSE) at baseline and at the 12-month follow-up. Statistical analyses included t-tests, χ 2 tests and multivariate regression analyses. Results: Butylphthalide was negatively associated with the MMSE D-value (β=−0.122; 95% CI −1.932 to −0.298; p=0.003) and the MMSE D-value percentage (β=−0.117; 95% CI −0.057 to −0.011; p=0.004). A multivariate analysis indicated that butylphthalide treatment was negatively associated with both changes in orientation and language score. Additionally, the incidence of cognitive decline was significantly lower in the butylphthalide group (OR, 0.612; p=0.020) than the control group. An age of ≥60 years and lower educational level were identified as risk factors for lower cognitive score and cognitive decline. Conclusion: This study demonstrated that butylphthalide is effective in preventing cognitive decline in patients with ischaemic stroke. These findings have significant implications for clinical practice, suggesting that butylphthalide could be incorporated into standard post-stroke care regimens to improve patient outcomes and reduce the healthcare burden. Additional multicentre double-blind trials are recommended to confirm these results in diverse populations.